FDA approves first rapid-acting insulin biosimilar for patients with diabetes
Aventis's Merilog (insulin-aspart-szjj) as a biosimilar to Novolog (insulin aspart) for adults and pediatric patients with ...
Medical News Today10h
Artificial sweetener may increase heart disease risk by triggering insulin surges
A common artificial sweetener may trigger insulin spikes that lead to the build up of fatty plaques in the arteries, ...